MORGAN STANLEY PLC/PUT/NOVO NORDISK ADR B/100/0.1/20.12.24 | Market Closed - Börse Stuttgart 12:47:57 06/07/2024 am IST | ||
| 0.103 EUR | +3.00% |
|
| Current month | +9.57% | ||
| 1 month | -7.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 0.103 | +3.00% |
| 04/24/04 | 0.1 | -19.35% |
| 03/24/03 | 0.124 | +25.25% |
| 02/24/02 | 0.099 | +15.12% |
| 01/24/01 | 0.086 | -8.51% |
Delayed Quote Börse Stuttgart
Last update July 06, 2024 at 12:47 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME1Z0Y |
| ISIN | DE000ME1Z0Y1 |
| Date issued | 12/10/2023 |
| Strike | 100 $ |
| Maturity | 20/12/2024 (168 Days) |
| Parity | 10 : 1 |
| Emission price | 1.41 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.47 € |
|---|---|
| Lowest since issue | 0.076 € |
| Delta | -0.06x |
| Omega | 7.788 |
| Premium | 30.56x |
| Gearing | 125.09x |
| Moneyness | 0.7024 |
| Difference Strike | -42.37 $ |
| Difference Strike % | -42.37% |
| Spread | 0.006 € |
| Spread % | 5.56% |
| Theoretical value | 0.1050 |
| Implied Volatility | 39.04 % |
| Total Loss Probability | 89.94 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1050 |
| Break even | 98.86 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | -0x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974
DKK
Average target price
952.2
DKK
Spread / Average Target
-2.24%
- Stock Market
- Warrants
- Warrant
